Marshall Wace, LLP Danaher Corp Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Danaher Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 1,095,411 shares of DHR stock, worth $253 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

1,095,411

Previous 1,908,492 42.6%

Holding current value

$253 Million

Previous $477 Million 36.14%

% of portfolio

0.39%

Previous 0.66%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$239.25 - $280.76 $195 Million - $228 Million	-813,081 Reduced 42.6%	1,095,411 $305 Million
Q2 2024 Aug 14, 2024	SELL	$235.51 - $267.98 $238 Million - $271 Million	-1,012,670 Reduced 34.67%	1,908,492 $477 Million
Q1 2024 May 15, 2024	BUY	$224.58 - $256.19 $257 Million - $293 Million	1,143,182 Added 64.3%	2,921,162 $729 Million
Q4 2023 Feb 14, 2024	SELL	$185.1 - $233.13 $107 Million - $135 Million	-578,582 Reduced 24.55%	1,777,980 $411 Million
Q3 2023 Nov 14, 2023	BUY	$233.08 - $265.59 $293 Million - $334 Million	1,258,472 Added 114.61%	2,356,562 $585 Million
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $60 Million - $68.3 Million	-266,542 Reduced 19.53%	1,098,090 $264 Million
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $136 Million - $157 Million	567,933 Added 71.29%	1,364,632 $344 Million
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $172 Million - $201 Million	710,584 Added 825.16%	796,699 $211 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $21.3 Million - $130 Million	86,115 New	86,115 $22.2 Million
Q2 2022 Aug 15, 2022	SELL	$237.11 - $299.66 $16.5 Million - $20.9 Million	-69,629 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $67.7 Million - $83.1 Million	-263,223 Reduced 79.08%	69,629 $20.4 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $57.1 Million - $64.3 Million	195,381 Added 142.13%	332,852 $110 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $96.2 Million - $117 Million	-353,378 Reduced 71.99%	137,471 $41.9 Million
Q2 2021 Aug 13, 2021	BUY	$225.08 - $271.69 $79.7 Million - $96.2 Million	354,200 Added 259.2%	490,849 $132 Million
Q1 2021 May 17, 2021	SELL	$212.38 - $245.9 $53.4 Million - $61.9 Million	-251,609 Reduced 64.8%	136,649 $30.8 Million
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $60 Million - $69.2 Million	282,120 Added 265.8%	388,258 $86.2 Million
Q3 2020 Nov 16, 2020	SELL	$177.16 - $215.33 $37.5 Million - $45.5 Million	-211,482 Reduced 66.58%	106,138 $22.9 Million
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $40.9 Million - $56.2 Million	317,620 New	317,620 $56.2 Million
Q1 2020 May 15, 2020	SELL	$121.39 - $169.05 $757,959 - $1.06 Million	-6,244 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$133.47 - $153.48 $73.1 Million - $84 Million	-547,413 Reduced 98.87%	6,244 $958,000
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $71 Million - $76.8 Million	524,602 Added 1805.55%	553,657 $80 Million
Q2 2019 Aug 14, 2019	SELL	$124.88 - $143.73 $11.4 Million - $13.1 Million	-91,120 Reduced 75.82%	29,055 $4.15 Million
Q1 2019 May 14, 2019	BUY	$97.62 - $132.29 $11.2 Million - $15.2 Million	114,533 Added 2030.01%	120,175 $15.9 Million
Q4 2018 Feb 14, 2019	SELL	$94.85 - $109.54 $5.2 Million - $6 Million	-54,808 Reduced 90.67%	5,642 $582,000
Q3 2018 Nov 14, 2018	BUY	$98.13 - $108.9 $4.99 Million - $5.54 Million	50,874 Added 531.27%	60,450 $6.57 Million
Q2 2018 Aug 14, 2018	BUY	$96.1 - $103.24 $920,253 - $988,626	9,576 New	9,576 $945,000
Q1 2018 May 15, 2018	SELL	$92.16 - $103.8 $1.6 Million - $1.81 Million	-17,412 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$85.26 - $94.62 $1.48 Million - $1.65 Million	17,412	17,412 $1.62 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

539M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Danaher Corp Transaction History